Revenue was 223.0 billion yen, up 12.3% year over year, with operating income of 14.9 billion yen, up 83.1% YoY. Segments Materials\/SU Quality of Life, Health Care, and Nutrition performed well. Going forward, growth strategies for each segment are expected to continue.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4118","jir_company_name":"Kaneka Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4118-20260813-02.pdf","jir_short_summary":"Revenue was 223.0 billion yen, up 12.3% year over year, with operating income of 14.9 billion yen, up 83.1% YoY. Segments Materials\/SU Quality of Life, Health Care, and Nutrition performed well. Going forward, growth strategies for each segment are expected to continue.","jir_summary":"### Business Performance Overview\nThe Q1 FY2027 results show revenue increasing year over year, with substantial increases in operating and ordinary income. Segments Material SU, Quality of Life SU, Health Care SU, and Nutrition SU showed solid performance, contributing to overall revenue and profit growth. New initiatives such as price adjustments and strengthening of stable supply contributed positively.\n\n### Outlook and Strategy\nFrom the second quarter onward, we will continue stable supply and pricing strategies across all segments. In particular, we will push expansion in Health Care and Nutrition, and seek to expand sales in overseas markets. We will continue measures aimed at responding to demand recovery in EV\/materials-related areas in global markets.","jir_financial_highlights":"Revenue: 2,230 (YoY +12.3%)\nOperating Income: 149 (YoY +83.1%)\nOrdinary Income: 138 (YoY +127.7%)","jir_category":"","jir_hashtags":"#Kaneka, #Earnings, #BusinessSegments, #QualityAndSupplyStability","jir_key_figures":"Revenue: 2,230 (YoY 12.3%)\nOperating Income: 149 (YoY 83.1%)\nOrdinary Income: 138 (YoY 127.7%)","jir_meta_title":"Kaneka FY2027 Q1 Earnings Summary | Revenue 223.0 billion yen, +12.3% YoY","jir_meta_description":"Kaneka FY2027 Q1 earnings summary. Revenue 223.0 billion yen, operating income 14.9 billion yen, ordinary income 13.8 billion yen. Segments trends and future strategy explained.","jir_og_title":"Kaneka FY2027 Q1 Earnings Summary","jir_og_description":"Kaneka earnings summary. Highlights of revenue and profits, segment trends, and outlook","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Q1\\\",\\\"Q2\\\",\\\"Q3\\\",\\\"Q4\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1987,2230,2100,2300]}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2027Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[82,149]}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Segment\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Material SU\\\",\\\"Quality of Life SU\\\",\\\"Health Care SU\\\",\\\"Nutrition SU\\\"],\\\"datasets\\\":[{\\\"data\\\":[124,98,45,50]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Profit Margin Analysis\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2027Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[4.1,6.7]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Actual vs Forecast\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Revenue\\\",\\\"Operating Income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Actual\\\",\\\"data\\\":[208,31]},{\\\"label\\\":\\\"Forecast\\\",\\\"data\\\":[220,35]}]}\"}]","ir_related_company":8200,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-103534","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n